We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBIN icon
13451
CALL
Merchants Bancorp
MBIN
$2.52B
$5.12K ﹤0.01%
200
-2,500
-93% -$61.9K
STRO icon
13452
PUT
Sutro Biopharma
STRO
$340M
$5.12K ﹤0.01%
110
AVNS
13453
PUT
DELISTED
Avanos Medical
AVNS
$5.11K ﹤0.01%
200
-1,200
-86% -$31.6K
DISTR
13454
DELISTED
Distoken Acquisition Corporation Right
DISTR
$5.11K ﹤0.01%
+24,753
New +$3.61K
BLACR
13455
DELISTED
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
$5.06K ﹤0.01%
+21,981
New +$3.83K
BLFY
13456
PUT
DELISTED
Blue Foundry Bancorp
BLFY
$5.05K ﹤0.01%
+500
New +$4.82K
ZIVOW
13457
DELISTED
Zivo Bioscience, Inc. Warrants
ZIVOW
$5.05K ﹤0.01%
+10,101
New +$6.22K
PDCE
13458
DELISTED
PDC Energy, Inc.
PDCE
$5.05K ﹤0.01%
71
-173,975
-100% -$11.8M
MDRX
13459
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
$5.04K ﹤0.01%
400
-2,000
-83% -$24.3K
BLND icon
13460
CALL
Blend Labs
BLND
$352M
$5.02K ﹤0.01%
5,300
-4,400
-45% -$3.9K
LAB icon
13461
CALL
Standard BioTools
LAB
$280M
$5.02K ﹤0.01%
2,600
-1,100
-30% -$2.17K
CINT icon
13462
PUT
CI&T Inc
CINT
$469M
$5.02K ﹤0.01%
+800
New +$3.86K
MRIN
13463
PUT
DELISTED
Marin Software
MRIN
$5.01K ﹤0.01%
1,417
-800
-36% -$3.5K
OSUR icon
13464
PUT
OraSure Technologies
OSUR
$265M
$5.01K ﹤0.01%
1,000
+900
+900% +$5.4K
HYMB icon
13465
CALL
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.36B
$5K ﹤0.01%
200
-2,200
-92% -$54.7K
HYMC icon
13466
PUT
Hycroft Mining Holding Corp
HYMC
$2.52B
$4.99K ﹤0.01%
1,690
-90
-5% -$341
CNOB icon
13467
PUT
Center Bancorp
CNOB
$1.79B
$4.98K ﹤0.01%
300
-600
-67% -$9.37K
PXJ icon
13468
PUT
Invesco Oil & Gas Services ETF
PXJ
$67.1M
$4.97K ﹤0.01%
200
-560
-74% -$13.4K
SLS icon
13469
SELLAS Life Sciences
SLS
$2.58B
$4.96K ﹤0.01%
+3,162
New +$5.08K
SFT
13470
PUT
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$4.94K ﹤0.01%
2,278
-100
-4% -$166
ACWX icon
13471
PUT
iShares MSCI ACWI ex US ETF
ACWX
$12B
$4.92K ﹤0.01%
+100
New +$4.92K
PPBT
13472
PUT
Purple Biotech
PPBT
$2.44M
$4.9K ﹤0.01%
18
-3
-14% -$1.08K
DIHP icon
13473
PUT
Dimensional International High Profitability ETF
DIHP
$6.59B
$4.9K ﹤0.01%
+200
New +$4.87K
DTIL icon
13474
CALL
Precision BioSciences
DTIL
$205M
$4.89K ﹤0.01%
310
-40
-11% -$915
ASLN
13475
CALL
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$4.89K ﹤0.01%
168
+88
+110% +$2.72K

Similar funds

Citadel Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.

  • Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Citadel Advisors opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.